SEARCH

SEARCH BY CITATION

References

  • 1
    Samuel D, Muller R, Graeme A, Fassati L, Ducot B, Benhamou JP, Bismuth H, and the investigators of The European Concerted Action on Viral Hepatitis Study. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993; 329:18421847.MEDLINE
  • 2
    Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 1991; 13:619626.MEDLINE
  • 3
    McGory RW, Ishitani MB, Oliveira WM, Stevenson WC, McCulough, Dickson RC, Caldwell SH, et al. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation 1996; 61:13581364.MEDLINE
  • 4
    Terrault NA, Zhou S, Combs C, Hahn JA, Lake JR, Roberts JP, Ascher NL, et al. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Hepatology 1996; 24:13271333.MEDLINE
  • 5
    Perrillo R, Schiff E, Dienstag J, Gish R, Dickson RC, Adams P, Brown N, et al. Lamivudine for prevention of recurrent hepatitis B after liver transplantation: final results of a U.S./Canadian multicenter trial [Abstract]. Hepatology 1999; 30:222A.
  • 6
    Grellier L, Mutimer D, Ahmed M, Brown D, Burroughs AK, Rolles K, McMaster P, et al. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet 1996; 348:12121215.MEDLINE
  • 7
    Mutimer D, Pillay D, Dragon E, Tang H, Ahmed M, O'Donnell K, Shaw J, et al. High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplant. J Hepatol 1999; 30:715721.MEDLINE
  • 8
    Markowitz JS, Martin P, Conrad AJ, Markmann JF, Seu P, Yersiz H, Goss JA, et al. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology 1998; 28:585589.MEDLINE
  • 9
    McCaughan GW, Spencer J, Koorey D, Bowden S, Bartholomeusz A, Littlejohn M, Verran D, et al. Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: high resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immune globulin. Liver Transpl Surg 1999; 5:512519.MEDLINE
  • 10
    Yao FY, Osorio RW, Roberts JP, Poordad FF, Briceno MN, Garcia-Kennedy R, Gish RR. Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation. Liver Transpl Surg 1999; 5:491496.MEDLINE
  • 11
    Rizzetto M, Recchia S, Salizzoni M. Liver transplantation in carriers of the HBsAg. J Hepatol 1991; 13:57.MEDLINE
  • 12
    Jacobs JM, Martin P, Munoz SJ, Westerberg S, Hann HW, Moritz MJ, Rubin R, et al. Liver transplantation for chronic hepatitis B in Asian males. Transpl Proc 1993; 25:19041906.
  • 13
    Jurim O, Martin P, Shaked A, Goldstein L, Millis JM, Calquhoun SD, Gitnick G, et al. Liver transplantation for chronic hepatitis B in Asians. Transplantation 1994; 57:13931395.MEDLINE
  • 14
    Ho BM, So SK, Esquivel CO, Keeffe EB. Liver transplantation in Asians patients with chronic hepatitis B. Hepatology 1997; 25:223225.MEDLINE
  • 15
    Huang EJ, Wright TL, Lake JR, Combs C, Ferrell LD. Hepatitis B and C co-infections and persistent hepatitis B infections: clinical outcome and liver pathology after transplantation. Hepatology 1996; 23:396404.MEDLINE